60

JiangXi Tianxin Pharmaceutical Co LtdSHG 603235 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Oct, 2024

Last price

Market cap $B

3.311

Middle

Exchange

XSHG - Shanghai Stock Exchange

603235.SS Stock Analysis

60

Uncovered

JiangXi Tianxin Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

87/100

Moderate score

Market cap $B

3.311

Dividend yield

2.00 %

Shares outstanding

437.78 B

JiangXi Tianxin Pharmaceutical Co Ltd is a CN-based company operating in Personal Products industry. The company is headquartered in Jingdezhen, Jiangxi and currently employs 2,404 full-time employees. The company went IPO on 2022-07-12. JiangXi Tianxin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of monomeric vitamin products. The firm's main products include vitamin B6, vitamin B1, biotin, folic acid, vitamin D3, ascorbyl palmitate, vitamin E powder, etc. Its products are mainly used in the fields of feed, medicine and food. The firm mainly conducts its businesses in domestic and overseas markets.

View Section: Eyestock Rating